{"downloaded": true, "htmlmade": false, "full": {"id": "33283236", "source": "MED", "pmid": "33283236", "pmcid": "PMC7937420", "fullTextIdList": {"fullTextId": "PMC7937420"}, "doi": "10.1093/jjco/hyaa221", "title": "Short-term results of a phase II study of preoperative docetaxel/cisplatin/S-1 therapy for locally advanced gastric cancer.", "authorString": "Tsuchida K, Sato T, Aoyama T, Atsumi Y, Kano K, Maezawa Y, Kazama K, Numata M, Yamada T, Tamagawa H, Murakami H, Oshima T, Saeki H, Cho H, Yukawa N, Yamamoto Y, Masuda M, Rino Y.", "authorList": {"author": [{"fullName": "Tsuchida K", "firstName": "Kazuhito", "lastName": "Tsuchida", "initials": "K", "authorAffiliationDetailsList": {"authorAffiliation": [{"affiliation": "Department of Surgery, Yokohama City University, 3-9, Fukuura, Kanazawa-ku, Yokohama City, Kanagawa, 236-0004 Japan."}, {"affiliation": "Department of Surgery, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, 3-18-22, Honkomagome, Bunkyo-ku, Tokyo, 113-8677 Japan."}]}}, {"fullName": "Sato T", "firstName": "Tsutomu", "lastName": "Sato", "initials": "T", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Department of Surgery, Yokohama City University, 3-9, Fukuura, Kanazawa-ku, Yokohama City, Kanagawa, 236-0004 Japan."}}}, {"fullName": "Aoyama T", "firstName": "Toru", "lastName": "Aoyama", "initials": "T", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Department of Surgery, Yokohama City University, 3-9, Fukuura, Kanazawa-ku, Yokohama City, Kanagawa, 236-0004 Japan."}}}, {"fullName": "Atsumi Y", "firstName": "Yosuke", "lastName": "Atsumi", "initials": "Y", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Department of Surgery, Yokohama City University, 3-9, Fukuura, Kanazawa-ku, Yokohama City, Kanagawa, 236-0004 Japan."}}}, {"fullName": "Kano K", "firstName": "Kazuki", "lastName": "Kano", "initials": "K", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Department of Surgery, Yokohama City University, 3-9, Fukuura, Kanazawa-ku, Yokohama City, Kanagawa, 236-0004 Japan."}}}, {"fullName": "Maezawa Y", "firstName": "Yukio", "lastName": "Maezawa", "initials": "Y", "authorAffiliationDetailsList": {"authorAffiliation": [{"affiliation": "Department of Surgery, Yokohama City University, 3-9, Fukuura, Kanazawa-ku, Yokohama City, Kanagawa, 236-0004 Japan."}, {"affiliation": "Department of Surgery, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, 3-18-22, Honkomagome, Bunkyo-ku, Tokyo, 113-8677 Japan."}]}}, {"fullName": "Kazama K", "firstName": "Keisuke", "lastName": "Kazama", "initials": "K", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Department of Surgery, Yokohama City University, 3-9, Fukuura, Kanazawa-ku, Yokohama City, Kanagawa, 236-0004 Japan."}}}, {"fullName": "Numata M", "firstName": "Masakatsu", "lastName": "Numata", "initials": "M", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Department of Surgery, Yokohama City University, 3-9, Fukuura, Kanazawa-ku, Yokohama City, Kanagawa, 236-0004 Japan."}}}, {"fullName": "Yamada T", "firstName": "Takanobu", "lastName": "Yamada", "initials": "T", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Department of Surgery, Yokohama City University, 3-9, Fukuura, Kanazawa-ku, Yokohama City, Kanagawa, 236-0004 Japan."}}}, {"fullName": "Tamagawa H", "firstName": "Hiroshi", "lastName": "Tamagawa", "initials": "H", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Department of Surgery, Yokohama City University, 3-9, Fukuura, Kanazawa-ku, Yokohama City, Kanagawa, 236-0004 Japan."}}}, {"fullName": "Murakami H", "firstName": "Hitoshi", "lastName": "Murakami", "initials": "H", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Department of Surgery, Yokohama City University, 3-9, Fukuura, Kanazawa-ku, Yokohama City, Kanagawa, 236-0004 Japan."}}}, {"fullName": "Oshima T", "firstName": "Takashi", "lastName": "Oshima", "initials": "T", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Department of Surgery, Yokohama City University, 3-9, Fukuura, Kanazawa-ku, Yokohama City, Kanagawa, 236-0004 Japan."}}}, {"fullName": "Saeki H", "firstName": "Hiroyuki", "lastName": "Saeki", "initials": "H", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Department of Surgery, Yokohama City University, 3-9, Fukuura, Kanazawa-ku, Yokohama City, Kanagawa, 236-0004 Japan."}}}, {"fullName": "Cho H", "firstName": "Haruhiko", "lastName": "Cho", "initials": "H", "authorAffiliationDetailsList": {"authorAffiliation": [{"affiliation": "Department of Surgery, Yokohama City University, 3-9, Fukuura, Kanazawa-ku, Yokohama City, Kanagawa, 236-0004 Japan."}, {"affiliation": "Department of Surgery, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, 3-18-22, Honkomagome, Bunkyo-ku, Tokyo, 113-8677 Japan."}]}}, {"fullName": "Yukawa N", "firstName": "Norio", "lastName": "Yukawa", "initials": "N", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Department of Surgery, Yokohama City University, 3-9, Fukuura, Kanazawa-ku, Yokohama City, Kanagawa, 236-0004 Japan."}}}, {"fullName": "Yamamoto Y", "firstName": "Yuji", "lastName": "Yamamoto", "initials": "Y", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Department of Surgery, Yokohama City University, 3-9, Fukuura, Kanazawa-ku, Yokohama City, Kanagawa, 236-0004 Japan."}}}, {"fullName": "Masuda M", "firstName": "Munetaka", "lastName": "Masuda", "initials": "M", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Department of Surgery, Yokohama City University, 3-9, Fukuura, Kanazawa-ku, Yokohama City, Kanagawa, 236-0004 Japan."}}}, {"fullName": "Rino Y", "firstName": "Yasushi", "lastName": "Rino", "initials": "Y", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Department of Surgery, Yokohama City University, 3-9, Fukuura, Kanazawa-ku, Yokohama City, Kanagawa, 236-0004 Japan."}}}]}, "journalInfo": {"issue": "3", "volume": "51", "journalIssueId": "3126895", "dateOfPublication": "2021 Mar", "monthOfPublication": "3", "yearOfPublication": "2021", "printPublicationDate": "2021-03-01", "journal": {"title": "Japanese journal of clinical oncology", "ISOAbbreviation": "Jpn J Clin Oncol", "medlineAbbreviation": "Jpn J Clin Oncol", "NLMid": "0313225", "ISSN": "0368-2811", "ESSN": "1465-3621"}}, "pubYear": "2021", "pageInfo": "371-378", "abstractText": "<h4>Background</h4>A multi-institutional phase II study was conducted to evaluate the efficacy and safety of preoperative docetaxel, cisplatin and S-1 therapy in marginally resectable advanced gastric cancer.<h4>Methods</h4>Patients with macroscopic type 4, large macroscopic type 3 and bulky lymph node metastasis received two cycles of preoperative docetaxel, cisplatin and S-1 therapy (docetaxel 40\u00a0mg/m2 and cisplatin 60\u00a0mg/m2 on day 1, and S-1 80\u00a0mg/m2 for 14\u00a0days, every 4\u00a0weeks). The primary endpoint was the pathological response rate, with an expected value of 65%.<h4>Results</h4>Thirty-one patients were enrolled in this study. The pathological response rate was 54.8%, and it was higher than the threshold value but lower than the expected rate. The R0 resection rate was 93.5%. The frequencies of grade 3-4 toxicities during docetaxel, cisplatin and S-1 therapy were 41.9% for neutropenia, 6.5% for febrile neutropenia and 32.3% for nausea/vomiting. Grade 2 and 3 surgical morbidities occurred in 23.3 and 6.7% of the patients, respectively.<h4>Conclusions</h4>Preoperative docetaxel, cisplatin and S-1 therapy was feasible in terms of chemotherapy-related toxicities and surgical morbidity, but the effect did not achieve the expected value. The association between the pathological response rate and survival will be evaluated in the final analysis of this clinical trial.", "affiliation": "Department of Surgery, Yokohama City University, 3-9, Fukuura, Kanazawa-ku, Yokohama City, Kanagawa, 236-0004 Japan.", "publicationStatus": "ppublish", "language": "eng", "pubModel": "Print", "pubTypeList": {"pubType": ["Clinical Trial, Phase II", "research-article", "Multicenter Study", "Journal Article"]}, "meshHeadingList": {"meshHeading": [{"majorTopic_YN": "N", "descriptorName": "Humans"}, {"majorTopic_YN": "N", "descriptorName": "Stomach Neoplasms", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DT", "qualifierName": "drug therapy", "majorTopic_YN": "Y"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "Y"}, {"abbreviation": "SU", "qualifierName": "surgery", "majorTopic_YN": "N"}]}}, {"majorTopic_YN": "N", "descriptorName": "Postoperative Complications", "meshQualifierList": {"meshQualifier": {"abbreviation": "ET", "qualifierName": "etiology", "majorTopic_YN": "N"}}}, {"majorTopic_YN": "N", "descriptorName": "Cisplatin", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AE", "qualifierName": "adverse effects", "majorTopic_YN": "N"}, {"abbreviation": "TU", "qualifierName": "therapeutic use", "majorTopic_YN": "Y"}]}}, {"majorTopic_YN": "N", "descriptorName": "Tegafur", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AE", "qualifierName": "adverse effects", "majorTopic_YN": "N"}, {"abbreviation": "TU", "qualifierName": "therapeutic use", "majorTopic_YN": "Y"}]}}, {"majorTopic_YN": "N", "descriptorName": "Oxonic Acid", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AE", "qualifierName": "adverse effects", "majorTopic_YN": "N"}, {"abbreviation": "TU", "qualifierName": "therapeutic use", "majorTopic_YN": "Y"}]}}, {"majorTopic_YN": "N", "descriptorName": "Antineoplastic Combined Chemotherapy Protocols", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AE", "qualifierName": "adverse effects", "majorTopic_YN": "N"}, {"abbreviation": "TU", "qualifierName": "therapeutic use", "majorTopic_YN": "Y"}]}}, {"majorTopic_YN": "N", "descriptorName": "Drug Combinations"}, {"majorTopic_YN": "N", "descriptorName": "Neoplasm Staging"}, {"majorTopic_YN": "Y", "descriptorName": "Preoperative Care"}, {"majorTopic_YN": "N", "descriptorName": "Dose-Response Relationship, Drug"}, {"majorTopic_YN": "N", "descriptorName": "Time Factors"}, {"majorTopic_YN": "N", "descriptorName": "Aged"}, {"majorTopic_YN": "N", "descriptorName": "Middle Aged"}, {"majorTopic_YN": "N", "descriptorName": "Female"}, {"majorTopic_YN": "N", "descriptorName": "Male"}, {"majorTopic_YN": "N", "descriptorName": "Docetaxel", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AE", "qualifierName": "adverse effects", "majorTopic_YN": "N"}, {"abbreviation": "TU", "qualifierName": "therapeutic use", "majorTopic_YN": "Y"}]}}]}, "keywordList": {"keyword": ["Gastric cancer", "Preoperative Chemotherapy", "Locally Advanced Cancer", "Docetaxel/cisplatin/s-1"]}, "chemicalList": {"chemical": [{"name": "S 1 (combination)", "registryNumber": "150863-82-4"}, {"name": "Drug Combinations", "registryNumber": "0"}, {"name": "docetaxel", "registryNumber": "15H5577CQD"}, {"name": "Cisplatin", "registryNumber": "Q20Q21Q62J"}, {"name": "Tegafur", "registryNumber": "1548R74NSZ"}, {"name": "Oxonic Acid", "registryNumber": "5VT6420TIG"}]}, "subsetList": {"subset": {"code": "IM", "name": "Index Medicus"}}, "fullTextUrlList": {"fullTextUrl": [{"availability": "Subscription required", "availabilityCode": "S", "documentStyle": "doi", "site": "DOI", "url": "https://doi.org/10.1093/jjco/hyaa221"}, {"availability": "Open access", "availabilityCode": "OA", "documentStyle": "html", "site": "Europe_PMC", "url": "https://europepmc.org/articles/PMC7937420"}, {"availability": "Open access", "availabilityCode": "OA", "documentStyle": "pdf", "site": "Europe_PMC", "url": "https://europepmc.org/articles/PMC7937420?pdf=render"}]}, "isOpenAccess": "Y", "inEPMC": "Y", "inPMC": "N", "hasPDF": "Y", "hasBook": "N", "hasSuppl": "N", "citedByCount": "0", "hasData": "N", "hasReferences": "Y", "hasTextMinedTerms": "Y", "hasDbCrossReferences": "N", "hasLabsLinks": "N", "license": "cc by", "authMan": "N", "epmcAuthMan": "N", "nihAuthMan": "N", "hasTMAccessionNumbers": "N", "dateOfCompletion": "2021-03-25", "dateOfCreation": "2020-12-07", "firstIndexDate": "2020-12-09", "fullTextReceivedDate": "2021-03-13", "dateOfRevision": "2021-03-25", "firstPublicationDate": "2021-03-01"}, "htmllinks": "https://europepmc.org/articles/PMC7937420", "abstract": "<h4>Background</h4>A multi-institutional phase II study was conducted to evaluate the efficacy and safety of preoperative docetaxel, cisplatin and S-1 therapy in marginally resectable advanced gastric cancer.<h4>Methods</h4>Patients with macroscopic type 4, large macroscopic type 3 and bulky lymph node metastasis received two cycles of preoperative docetaxel, cisplatin and S-1 therapy (docetaxel 40\u00a0mg/m2 and cisplatin 60\u00a0mg/m2 on day 1, and S-1 80\u00a0mg/m2 for 14\u00a0days, every 4\u00a0weeks). The primary endpoint was the pathological response rate, with an expected value of 65%.<h4>Results</h4>Thirty-one patients were enrolled in this study. The pathological response rate was 54.8%, and it was higher than the threshold value but lower than the expected rate. The R0 resection rate was 93.5%. The frequencies of grade 3-4 toxicities during docetaxel, cisplatin and S-1 therapy were 41.9% for neutropenia, 6.5% for febrile neutropenia and 32.3% for nausea/vomiting. Grade 2 and 3 surgical morbidities occurred in 23.3 and 6.7% of the patients, respectively.<h4>Conclusions</h4>Preoperative docetaxel, cisplatin and S-1 therapy was feasible in terms of chemotherapy-related toxicities and surgical morbidity, but the effect did not achieve the expected value. The association between the pathological response rate and survival will be evaluated in the final analysis of this clinical trial.", "Keywords": ["Gastric cancer", "Preoperative Chemotherapy", "Locally Advanced Cancer", "Docetaxel/cisplatin/s-1"], "pdflinks": "https://europepmc.org/articles/PMC7937420?pdf=render", "journaltitle": "Japanese journal of clinical oncology", "authorinfo": ["Tsuchida K", "Sato T", "Aoyama T", "Atsumi Y", "Kano K", "Maezawa Y", "Kazama K", "Numata M", "Yamada T", "Tamagawa H", "Murakami H", "Oshima T", "Saeki H", "Cho H", "Yukawa N", "Yamamoto Y", "Masuda M", "Rino Y"], "title": "Short-term results of a phase II study of preoperative docetaxel/cisplatin/S-1 therapy for locally advanced gastric cancer."}